Long term follow-up of “full metal jacket” of de novo coronary lesions with new generation Zotarolimus-eluting stents

Alessandro Durante, Giovanni Foglia Manzillo, Francesco Burzotta, Carlo Trani, Cristina Aurigemma, Francesco Summaria, Roberto Patrizi, Giovanni Paolo Talarico, Azeem Latib, Filippo Figini, Enrico Romagnoli, Mariarosaria De Vita, Cecilia Fantoni, Luigi My, Claudio Larosa, Alessandro Manzoli, Maurizio Turturo, Andrea Berni, Giovanni Corrado

Risultato della ricerca: Contributo in rivistaArticolo in rivista

5 Citazioni (Scopus)


Background Diffuse coronary artery disease treatment still remains a challenge for interventional cardiologists and cardiac surgeons. There are few data on full metal jacket (FMJ) stenting, especially with new-generation drug-eluting stents. We aimed to assess the efficacy and safety of FMJ with new-generation Zotarolimus-eluting stents (n-ZES). Methods and results All patients who underwent FMJ with n-ZES (≥ 60 mm stent length) in eleven Italian interventional centers participating in the Clinical Service® project were included in this analysis. The project population consisted of 120 patients and 122 lesions. Mean age was 67 ± 10 years and 95 (79.2%) patients were male. A chronic total occlusion was present in 34 lesions (27.9%). The number of stents implanted per lesion was 2.9 ± 0.8, and the diameter of the stents was 3.0 ± 0.5 mm. Predilation and post-dilatation were performed in 107 (87.7%) and 92 (75.4%) patients, respectively. At 41 ± 21 month follow-up there were 2 patients with subacute definite stent thrombosis, 6 patients (5.0%) had cardiac death and 5 patients (4.2%) had non-fatal myocardial infarction. Seven patients (5.8%) underwent clinically-driven target lesion revascularization. Fourteen patients (11.7%) had at least one major adverse cardiac event. Conclusion The treatment of diffuse coronary artery disease with FMJ stenting with n-ZES appears to be effective and safe. Late and very-late ST does not seem to be an issue and the rate of restenosis and of major cardiac adverse events after more than 3-year follow-up is rather low.
Lingua originaleEnglish
pagine (da-a)1008-1012
Numero di pagine5
RivistaInternational Journal of Cardiology
Stato di pubblicazionePubblicato - 2016


  • Cardiology and Cardiovascular Medicine
  • DES
  • Drug eluting stent
  • Full metal jacket
  • Medicine (all)
  • PCI
  • ZES


Entra nei temi di ricerca di 'Long term follow-up of “full metal jacket” of de novo coronary lesions with new generation Zotarolimus-eluting stents'. Insieme formano una fingerprint unica.

Cita questo